Abstract:Background and Purpose-Stroke is a major public health concern worldwide. Although clinical treatments have improved in the acute period after stroke, long-term therapeutics remain limited to physical rehabilitation in the delayed phase. This study is aimed to determine whether nNOS (neuronal NO synthase)-CAPON (carboxy-terminal postsynaptic density-95/ discs large/zona occludens-1 ligand of nNOS) interaction may serve as a new therapeutic target in the delayed phase for stroke recovery. Methods-Photothrombotic stroke and transient middle cerebral artery occlusion were induced in mice. Adeno-associated virus (AAV)-cytomegalovirus (CMV)-CAPON-125C-GFP (green fluorescent protein)-3Flag and the other 2 drugs (Tat-CAPON-12C and ZLc-002) were microinjected into the peri-infarct cortex immediately and 4 to 10 days after photothrombotic stroke, respectively. ZLc-002 was also systemically injected 4 to 10 days after transient middle cerebral artery occlusion. Grid-walking task and cylinder task were conducted to assess motor function. Western blotting, immunohistochemistry, Golgi staining, and electrophysiology recordings were performed to uncover the mechanisms. Results-Stroke increased nNOS-CAPON association in the peri-infarct cortex in the delayed period. Inhibiting the ischemia-induced nNOS-CAPON association substantially decreased the number of foot faults in the grid-walking task and forelimb asymmetry in the cylinder task, suggesting the promotion of functional recovery from stroke. Moreover, dissociating nNOS-CAPON significantly facilitated dendritic remodeling and synaptic transmission, indicated by increased dendritic spine density, dendritic branching, and length and miniature excitatory postsynaptic current frequency but did not affect stroke-elicited neuronal loss, infarct size, or cerebral edema, suggesting that nNOS-CAPON interaction may function via regulating structural neuroplasticity, rather than neuroprotection. Furthermore, ZLc-002 reversed the transient middle cerebral artery occlusion-induced impairment of motor function. Conclusions-Our results reveal that nNOS-CAPON coupling can serve as a novel pharmacological target for functional restoration after stroke. Visual Overview-An online visual overview is available for this article. (Stroke. 2019;50:728-737. DOI: 10.1161/STROKEAHA.118.022647.)

The Dopamine Transporter Is a New Target for Ischemic Stroke

Network-Based Approach to Identify Potential Targets and Drugs That Promote Neuroprotection and Neurorepair in Acute Ischemic Stroke

Autophagy Upregulation and Apoptosis Downregulation in DAHP and Triptolide Treated Cerebral Ischemia.

Neuroprotective Effect of DAHP Via Antiapoptosis in Cerebral Ischemia

Signaling Pathways in Brain Ischemia: Mechanisms and Therapeutic Implications.

Salvaging Brain Ischemia by Increasing Neuroprotectant Uptake Via Nanoagonist Mediated Blood Brain Barrier Permeability Enhancement

D1 Receptor‐mediated Endogenous Tpa Upregulation Contributes to Blood‐brain Barrier Injury after Acute Ischaemic Stroke

Glutamate excitotoxicity: Potential therapeutic target for ischemic stroke

Role of Nadph Oxidase in Total Salvianolic Acid Injection Attenuating Ischemia-Reperfusion Impaired Cerebral Microcirculation and Neurons: Implication of Ampk/Akt/Pkc

Exogenous glutathione exerts a therapeutic effect in ischemic stroke rats by interacting with intrastriatal dopamine

Excitatory Synaptic Transmission in Ischemic Stroke: A New Outlet for Classical Neuroprotective Strategies

L-DOPA ameliorates hippocampus-based mitochondria respiratory dysfunction caused by GCI/R injury

Protection of Neuronal Cells from Excitotoxicity by Disrupting Nnos-Psd95 Interaction with a Small Molecule SCR-4026.

DDAH-1, via regulation of ADMA levels, protects against ischemia-induced blood-brain barrier leakage

Dissociation of Nnos from PSD-95 Promotes Functional Recovery after Cerebral Ischaemia in Mice Through Reducing Excessive Tonic GABA Release from Reactive Astrocytes.

DUSP10 alleviates ischemic stroke-induced neuronal damage by restricting p38/JNK pathway

Dissociating nNOS (Neuronal NO Synthase)-CAPON (Carboxy-Terminal Postsynaptic Density-95/Discs Large/Zona Occludens-1 Ligand of nNOS) Interaction Promotes Functional Recovery After Stroke via Enhanced Structural Neuroplasticity.

The IC87201 (a PSD95/nNOS Inhibitor) Attenuates Post- Stroke Injuries

Involvement of DAAO Overexpression in Delayed Hippocampal Neuronal Death

Metabolomic Profiling of Brain Protective Effect of Edaravone on Cerebral Ischemia-Reperfusion Injury in Mice

DDAH1 promotes neurogenesis and neural repair in cerebral ischemia